What is COMPASS?
The ChicagO Multiethnic Prevention And Surveillance Study (COMPASS) is designed by researchers at the University of Chicago Medicine Comprehensive Cancer Center to understand how lifestyle, healthcare, environment, and genetics affect health.
It is known that certain racial or population sub-groups have higher rates of occurrence or severity of cancer and chronic diseases, such as diabetes, cardiovascular, and respiratory illnesses. In Chicago, this disparity is often worse than in other parts of the United States. COMPASS aims to find out why.
This type of study of a large population-representative group of people over an extended period of time has never been done before. The knowledge we acquire will be valuable and applicable to the general population throughout the nation.
– Dr. Habibul Ahsan, principal investigator
By participating in COMPASS you will help improve the health of your community, and contribute to the advancement of scientific research.
The University of Chicago Medicine Comprehensive Cancer Center
At the forefront of cancer care and discovery. Learn more.
COMPASS will recruit approximately 10,000 participants in the initial phase of the project and will eventually expand the study to include up to 100,000 residents.
Your contribution will benefit people now and in the future by bringing us closer to understanding the causes of cancer and chronic diseases.
You can be a part of this groundbreaking research!
